All News

All stakeholders across the drug supply chain must work together to develop and support proactive strategies, creating resilience across the health care ecosystem to avoid and mitigate shortages.

At 12 and 24 months, there were 56.9% and 73.5% reductions in food-specific immunoglobulin E (IgE).

The approval fills a treatment gap for patients with this rare disease, which can severely diminish quality of life.

Optimal glycemic control and medication delivery rely upon proper tools and techniques.

Interim results from an observational trial of patients with myelofibrosis indicate upward trends in health-related quality of life when started on the highest tolerable dose of ruxolitinib.

Patients with chronic lymphocytic leukemia (CLL) show weakened T-cell memory responses to COVID-19 vaccination.

Community health workers improve patient care and address health care access gaps.

Using Janus kinase inhibitors, having experienced a previous thrombosis episode, and higher age were associated with a heightened risk of a new thromboembolic event.

The findings provide a deeper understanding of the mechanisms underlying breast cancer progression and treatment resistance.

In previously sedentary young males and females, 14 days of moderate aerobic exercise increased red and white blood cell counts and hemoglobin concentrations without altering key cardiometabolic enzymes.

Will traditional PBMs adapt, or will disruptors take over?

About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.

Patients achieved statistically significant benefits in progression-free survival and overall response rates.

The hepatitis B core-related antigen (HBcrAg) rapid diagnostic test was more timely and showed a stronger sensitivity and specificity compared with other testing methods.

Older age and being insured with Medicare or Medicaid were associated with heightened annual joint bleeding rates, whereas treatment in the Northeast United States improved outcomes in both hemophilia A and hemophilia B.

Managing the challenge requires a multifaceted approach with all stakeholders.

Gepotidacin is indicated for female patients who are at least 12 years of age and weigh at least 40 kg with uncomplicated urinary tract infections (uUTIs) caused by certain microorganisms.

If approved, this novel monoclonal antibody therapy could become a standard of care emergency option for patients with acute myocardial infarction, which affects millions in the United States and across the world.

As the COVID-19 pandemic moves into an endemic phase, the major impacts on drug research, collaboration, and use of new technologies due to the spread of the virus warrant recognition.

Pharmacists can promote prevention through the implementation of antimicrobial stewardship initiatives and advocate for fecal microbiota transplant.

Although PBMs claim integration reduces costs and improves efficiency, the reality is more complicated—and often leaves patients footing the bill.

A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.

Helping patients adhere to their medications to manage their chronic kidney disease (CKD) and comorbidities is one of the key areas pharmacists should prioritize.

Pharmacy technicians can elevate their careers by developing leadership skills, pursuing specialized certifications, and embracing continuous professional growth.

Megan May, PharmD, BCOP, FHOPA, FAPO, discusses lurbinectedin and tarlatamab and what ongoing research in the small cell lung cancer (SCLC) space entails.

This new podcast will explore the latest evidence, practices, and innovations in the world of cardiovascular care from a pharmacist's point of view.

The legislation is expected to improve the financial stability of independent and community pharmacies by ensuring fair reimbursement rates and allowing them to better manage their finances.

Evidence-based guidelines support the safe and effective administration of Ig therapy in clinical practice.